Illustratieve AI-afbeelding van een kat; geen foto uit het onderzoek

VIP and PACAP: vascular responses compared in cats

VIP / PACAP appears in scientific publications, but to properly understand a study, it must be clear what was actually tested. This article focuses on one original publication. We distinguish the measured outcome from possible applications in dogs, cats, and horses.

What was studied?

Anesthetized cats; controlled blood flow.

What did the researchers report?

The authors compared two related signaling peptides in the pulmonary and hindquarters vascular beds. The study focused on differences in vascular responses and pressure changes under controlled conditions.

What are the limitations?

PACAP and VIP are different molecules. Results for one peptide must not automatically be attributed to the other. A controlled vascular model is not a general safety test.

What does this mean for pet owners?

For pet owners, the distinction between research and treatment is particularly important. An experiment can clarify a biological mechanism without showing that a research product is suitable for a sick animal. The original publication is therefore a starting point for knowledge, not instructions for use.

Why are related peptides not interchangeable?

Molecules can resemble each other and still differ in receptor binding, breakdown, and organ response. Therefore, the result must always be linked to the substance actually tested.

Official research source

PubMed PMID 1568976

Source publication: Differential effects of PACAP and VIP on the pulmonary and hindquarters vascular beds of the cat. Summary based on the consulted source data; not a full systematic review.

For educational research purposes only. Research products are not intended for administration to humans or animals. This article does not contain veterinary treatment advice; discuss health concerns with a veterinarian.

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.